who performed the Focal One procedure on Tuesday, January 28th, 2025. “I am quite optimistic that this technology will help improve and standardize prostate MRI interpretation in multiple ...

First Focal One ® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of California, San Francisco Prostate Cancer Center ...

procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of California, San Francisco Prostate Cancer Center OnQ Prostate’s ...

First Focal One ® procedure utilizing Cortechs.ai's advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of California, San Francisco Prostate Cancer Center OnQ ...

These are the codes in our Radiology paper 'Diffusion-Time-Dependent Diffusion MRI for Quantitative Microstructural Mapping of Prostate Cancer: A Proof-of-Concept Study' ...

Purpose: We investigate the feasibility of data-driven, model-free quantitative MRI (qMRI) protocol design on in vivo brain and prostate diffusion-relaxation imaging (DRI). Results: In both brain and ...

Serum prostate-specific antigen was3.4 ng/ml. Bone scintigraphy and baseline CT were reportedlynegative. Investigations: Physical examination, laboratory evaluation,endorectal MRI of the prostate ...

Cortechs.ai and EDAP TMS (EDAP) announced the successful completion of the world’s first OnQ Prostate-assisted Focal One Robotic HIFU procedure ... solution for RSI-MRI, OnQ Prostate uniquely ...

A STUDY conducted by researchers in Berlin, Germany has found that using MRI as a first step in prostate cancer detection is safe and effective for at least three years. This study has shown that ...

If your healthcare provider suspects your cancer might be spreading, they will likely order more imaging tests. A common imaging workup may include a bone scan and a CT scan of the abdomen and pelvis.

The results can be directly exported for fusion biopsy procedures. QP-Prostate provides a High (orange) and Moderate (yellow) risk level, according to the risk of csPCa calculated by the software.